Raleigh Hematology Oncology Associates — Raleigh, North Carolina

Raleigh Hematology Oncology Associates is a clinical research site located in Raleigh, North Carolina, United States 27607.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Raleigh Hematology Oncology Associates has participated in 14 clinical trials.

Therapeutic areas: Prostate Cancer, Breast Cancer, Small Cell Lung Cancer.

Sponsors: Bristol-Myers Squibb, Eisai Inc., Celgene.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Raleigh Hematology Oncology Associates?

Raleigh Hematology Oncology Associates has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Raleigh Hematology Oncology Associates conducted?

Raleigh Hematology Oncology Associates has 14 clinical trials on record. Their work covers Prostate Cancer, Breast Cancer, Small Cell Lung Cancer.

Is Raleigh Hematology Oncology Associates accredited by Crixeo Health?

Yes — Raleigh Hematology Oncology Associates holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Raleigh Hematology Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.